Clinical Trials in Boston

Showing 641-660 of 8,503 trials

Body Acceptance After Baby Intervention

NCT07422571

The purpose of this study is to learn if a novel online single-session intervention can help improve body dissatisfaction in new moms. The active intervention condition, Body Acceptance After Baby (BABI), uses acceptance-based skills to help participants cope with body dissatisfaction. BABI will be evaluated against another active intervention condition (a brief infographic that provides psychoeducation about body image during postpartum) and a waitlist control condition.

Body Dissatisfaction

Northeastern University375 participantsStarted Jan 2026

Boston, Massachusetts, United States

RECRUITINGEARLY_PHASE1< 1 mile

Improving Outcomes of Older Adults Undergoing Ostomy Surgery

NCT07424586

The goal of this pilot study is to learn if an intervention in patients undergoing ostomy surgery is easy to use. The overall goal of the work is to improve quality of life during recovery in the days after surgery for these patients using the intervention.

Ostomy - Ileostomy or Colostomy

Massachusetts General Hospital16 participantsStarted Feb 2026

Boston, Massachusetts, United States

COMPLETEDPHASE1< 1 mile

DAY101 In Gliomas and Other Tumors

NCT03429803

This research study is studying a drug Tovorafenib/DAY101 (formerly TAK-580, MLN2480) as a possible treatment a low-grade glioma that has not responded to other treatments. The name of the study drug involved in this study is: • Tovorafenib/DAY101 (formerly TAK-580, MLN2480)

Low-grade Glioma

Karen D. Wright, MD44 participantsStarted Feb 2018

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +12 more locations

Body Acceptance After Baby Intervention

Improving Outcomes of Older Adults Undergoing Ostomy Surgery

DAY101 In Gliomas and Other Tumors

Find Trials by Condition in Boston

Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial

Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults

Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes